BRTX
Price
$1.11
Change
+$0.01 (+0.91%)
Updated
Dec 12 closing price
Capitalization
9.85M
103 days until earnings call
Intraday BUY SELL Signals
INRLF
Price
$4.26
Change
+$0.05 (+1.19%)
Updated
Dec 10 closing price
Capitalization
773.75M
Intraday BUY SELL Signals
Interact to see
Advertisement

BRTX vs INRLF

Header iconBRTX vs INRLF Comparison
Open Charts BRTX vs INRLFBanner chart's image
BioRestorative Therapies
Price$1.11
Change+$0.01 (+0.91%)
Volume$11.76K
Capitalization9.85M
Valneva SE
Price$4.26
Change+$0.05 (+1.19%)
Volume$4K
Capitalization773.75M
BRTX vs INRLF Comparison Chart in %
BRTX
Daily Signal:
Gain/Loss:
INRLF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BRTX vs. INRLF commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Hold and INRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (BRTX: $1.10 vs. INRLF: $4.26)
Brand notoriety: BRTX and INRLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 15% vs. INRLF: 668%
Market capitalization -- BRTX: $9.85M vs. INRLF: $773.75M
BRTX [@Biotechnology] is valued at $9.85M. INRLF’s [@Biotechnology] market capitalization is $773.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 0 FA rating(s) are green whileINRLF’s FA Score has 0 green FA rating(s).

  • BRTX’s FA Score: 0 green, 5 red.
  • INRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, INRLF is a better buy in the long-term than BRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 6 TA indicator(s) are bullish while INRLF’s TA Score has 5 bullish TA indicator(s).

  • BRTX’s TA Score: 6 bullish, 2 bearish.
  • INRLF’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, both BRTX and INRLF are a good buy in the short-term.

Price Growth

BRTX (@Biotechnology) experienced а -0.90% price change this week, while INRLF (@Biotechnology) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

BRTX is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INRLF($774M) has a higher market cap than BRTX($9.85M). INRLF YTD gains are higher at: 103.828 vs. BRTX (-23.077). BRTX has higher annual earnings (EBITDA): -14.3M vs. INRLF (-71.86M). INRLF has more cash in the bank: 143M vs. BRTX (4.49M). BRTX has less debt than INRLF: BRTX (42.4K) vs INRLF (196M). INRLF has higher revenues than BRTX: INRLF (180M) vs BRTX (383K).
BRTXINRLFBRTX / INRLF
Capitalization9.85M774M1%
EBITDA-14.3M-71.86M20%
Gain YTD-23.077103.828-22%
P/E RatioN/AN/A-
Revenue383K180M0%
Total Cash4.49M143M3%
Total Debt42.4K196M0%
FUNDAMENTALS RATINGS
BRTX vs INRLF: Fundamental Ratings
BRTX
INRLF
OUTLOOK RATING
1..100
422
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
8944
P/E GROWTH RATING
1..100
10073
SEASONALITY SCORE
1..100
5044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRTX's Valuation (36) in the null industry is in the same range as INRLF (54). This means that BRTX’s stock grew similarly to INRLF’s over the last 12 months.

BRTX's Profit vs Risk Rating (100) in the null industry is in the same range as INRLF (100). This means that BRTX’s stock grew similarly to INRLF’s over the last 12 months.

INRLF's SMR Rating (96) in the null industry is in the same range as BRTX (98). This means that INRLF’s stock grew similarly to BRTX’s over the last 12 months.

INRLF's Price Growth Rating (44) in the null industry is somewhat better than the same rating for BRTX (89). This means that INRLF’s stock grew somewhat faster than BRTX’s over the last 12 months.

INRLF's P/E Growth Rating (73) in the null industry is in the same range as BRTX (100). This means that INRLF’s stock grew similarly to BRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRTXINRLF
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
63%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
64%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
BRTX
Daily Signal:
Gain/Loss:
INRLF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPRI26.710.70
+2.69%
Capri Holdings Limited
TROW104.961.40
+1.35%
T Rowe Price Group
NEOV3.810.03
+0.79%
NeoVolta
EEX3.63-0.04
-1.09%
Emerald Holding
DSS1.01-0.02
-1.94%
DSS

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
N/A
TCRT - BRTX
33%
Loosely correlated
-0.93%
CDXS - BRTX
31%
Poorly correlated
-6.04%
GRCE - BRTX
28%
Poorly correlated
-0.88%
MRNA - BRTX
28%
Poorly correlated
+2.07%
CYYNF - BRTX
26%
Poorly correlated
N/A
More

INRLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, INRLF has been loosely correlated with VALN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INRLF jumps, then VALN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INRLF
1D Price
Change %
INRLF100%
N/A
VALN - INRLF
42%
Loosely correlated
+0.79%
IKT - INRLF
22%
Poorly correlated
+3.04%
IMMX - INRLF
21%
Poorly correlated
+9.66%
NBTX - INRLF
20%
Poorly correlated
+3.11%
ISCO - INRLF
5%
Poorly correlated
+24.91%
More